医薬品開発業務受託機関（CROs）市場レポート：2023-2033

Contract Research Organisations (CROs) Market Report 2023-2033

レポート詳細医薬品開発業務受託機関（CROs）市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年9月14日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	353	342	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

医薬品開発業務受託機関（CROs）市場レポート 2023-2033:本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな地域での既存事業の拡大を希望する企業にとっても有用であろう。

バイオ医薬品市場は上昇傾向にあり、高齢化により医療ニーズが高まり、バイオテクノロジー、製薬、医療機器産業はこの需要を満たすために拡大している。その結果、製品の有効性と安全性を確保するため、効果的な臨床試験の需要が高まっている。世界では、約26万6千件の公開臨床試験が進行中である。現在、米国だけでも10万5,000件以上のオープン臨床試験が実施されている。

一般的でない疾病の負担は国際的に増加しており、それが医薬品の増加や革新につながっている。末期希少疾患のうち、毎年初回治療を受けられるのはごく一部であり、これらの疾患の90％以上が治療法の承認を待っているのは事実である。2021年、CDCの報告によると、世界人口のほぼ10％にあたる4億7,500万人が希少疾病と共存していると考えられている。今後5年間で1520万人が希少疾患の臨床遺伝子検査を受けると予測されている。希少疾病の患者を支援するための政府プログラムを実施する国が増加している。

知的財産権の問題が業界の成長を阻む可能性が高い
知的財産は臨床試験をアウトソーシングする際の重要な障壁の一つであり、開発業務受託機関の市場拡大を制限する可能性がある。著作権で保護された製品が治療薬候補の大半を占めるため、開発業務受託機関はデータ漏洩の危険性を高める可能性がある。

さらに、新薬を開発する製薬会社は、その治療法が承認されるために、安全性と有効性に関する臨床データを関連する政府機関や規制機関に提供することが期待されている。そのため、特許付与前後の不服申し立てや特許に関する問題のガイドラインは非常に厳しい。しかし、これは検査の効率を向上させ、特許の取り消しに役立っている。臨床試験に関する問題についても、政府は徹底的に評価するため、臨床試験契約をより重視することは極めて重要である。しかし、このような問題はCROの評判を下げ、開発業務受託機関の分野拡大を妨げる可能性がある。

市場調査レポートを購入する前にすべき質問とは？
- 医薬品開発業務受託（CROs）市場はどのように進化しているのか？
- 医薬品開発業務受託（CROs）市場を牽引する要因と阻害要因は何か？
- ポイントオブケア診断の各サブ市場セグメントは予測期間中にどのように成長し、2033年にはどれくらいの売上を占めるようになるのか？
- 2022年から2033年にかけての各サブマーケットの市場シェアはどのように推移するか？
- 2023年から2033年にかけて市場全体を牽引する主な要因は何か？
- 主要な医薬品開発業務受託機関（CROs）市場はマクロ経済の動きに大枠で追随するのか、それとも各国市場が他を凌駕するのか。
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年の市場をリードするのか？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これらの大手企業の医薬品開発業務受託機関（CROs）プロジェクトはどのようなものか？
- 2023年から2033年にかけて、業界はどのように発展していくのか？現在および今後10年間に実施される開発業務受託（CROs）プロジェクトにはどのような意味があるのか？
- 医薬品開発業務受託機関（CROs）市場をさらに拡大するために、製品の商業化の必要性は高まっているのでしょうか？
- 医薬品開発業務受託機関（CROs）市場はどこに向かっているのか、そしてどのようにすれば市場の最前線に立てるのか？
- 新製品やサービスラインへの最適な投資方法とは？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

医薬品開発業務受託機関（CROs）市場が現在、そして今後10年間でどのような影響を受けるかを知る必要がある：
- 353ページにわたる本レポートでは、141の表、201の図表、グラフを掲載しています。
- 本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
- 本レポートには、世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、医薬品開発業務受託機関（CROs）市場が今後10年間にどのように発展していくのか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展していくのかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。

2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 質的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、医薬品開発業務受託機関（CROs）価格上昇の影響、最新動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

サービス
・前臨床
・臨床試験
- フェーズI
- フェーズII
- フェーズIII
- フェーズIV
・ラボサービス
・コンサルティングサービス
・データ管理サービス

企業規模
- 大手製薬・バイオテクノロジー企業
- 中堅製薬・バイオテクノロジー企業
- 小規模製薬会社

医薬品タイプ
- 低分子
- 大分子

治療領域
- がん領域
- 中枢神経系
- 循環器領域
- 感染症
- 代謝
- その他の治療領域

世界市場全体と各分野の売上予測に加え、5つの地域と25の主要国市場の売上予測も掲載しています：

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- スイス
- オランダ
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- シンガポール
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ

MEA
- GCC
- 南アフリカ
- エジプト
- その他のMEA

本レポートでは、医薬品開発業務受託機関（CROs）市場の2023年から2033年にかけての主要企業のプロファイルも掲載しています。

主要企業と市場成長の可能性
・ Allucent
・ Anthem Biosciences Private Limited
・ Bio-Techne
・ Charles River Laboratories
・ Caidya
・ CMIC HOLDINGS Co., Ltd.
・ Eurofins Scientific
・ Evotec SE
・ Frontage Labs
・ ICON plc
・ Inotiv
・ IQVIA Inc.
・ Labcorp Drug Development
・ Medpace
・ Parexel International (MA) Corporation
・ PPD (Thermo Fisher Scientific Inc.)
・ Syneos Health
・ Syngene International Limited
・ The Emmes Company, LLC
・ Worldwide Clinical Trials
・ Wuxi AppTec

世界の医薬品開発業務受託機関（CROs）市場全体の売上高は、金額ベースで2023年に680億米ドルを突破する。2033年まで売上は力強く成長すると予測している。当社の調査では、最も大きな可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見し、あなたが一歩先を行くのを支援します。

この調査レポートは医薬品開発業務受託機関（CROs）市場の2023年から2033年までを分析・予測したものです。
要約すると、350ページを超えるこのレポートは、以下の知識を提供する：

- 医薬品開発業務受託機関（CROs）市場の2023年から2033年までの収益予測、サービス、企業規模、医薬品タイプ、治療分野の各予測を世界レベルと地域レベルで掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。

- 5つの地域と25の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの医薬品開発業務受託機関（CROs）市場の2023年から2033年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、スペイン、スイス、オランダ、中国、インド、日本、オーストラリア、韓国、シンガポール、アルゼンチン、GCC、南アフリカ、エジプトなどの主要経済圏の市場も予測しています。

- 既存企業および市場参入を目指す企業の展望 - 医薬品開発業務受託機関（CROs）市場に関与する主要企業21社の企業プロファイルを含む、2023年から2033年までの市場。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。Visiongainのレポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainのこの調査レポートは、医薬品開発業務受託機関（CROs）市場の2023年から2033年までの商業分析を必要とするすべての人、市場をリードする企業を対象としています。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1 レポート概要
1.1 調査の目的
1.2 医薬品開発業務受託機関（CROs）市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 世界的な臨床試験需要の高まり
3.2.1.2 世界的な疾病負担の増加がCROs市場の成長を促進
3.2.1.3 製薬会社やバイオテクノロジー企業によるR&D投資の増加がCROs市場の成長を促進する
3.2.1.4 特許切れとジェネリック医薬品需要の増加がCRO全体の成長を促進する
3.2.1.5 高い自社開発コスト
3.2.2 市場阻害要因
3.2.2.1 知的財産権の問題がCROs産業の成長を妨げる可能性
3.2.2.2 COVID-19 後の熟練労働者不足が CROs 産業を妨げる
3.2.3 市場機会
3.2.3.1 人工知能の応用により、臨床試験の迅速化、安全化、大幅なコスト削減が期待できる
3.2.3.2 生物学的治療に対する需要の高まりがCROsに有利な成長展望をもたらす
3.2.3.3 核医学分野の成長
3.3 COVID-19インパクト分析
3.4 ポーターのファイブフォース分析
3.4.1 競争力：高い
3.4.2 新規参入の脅威：低～中
3.4.3 代替品の脅威：低～中低～中
3.4.4 買い手の交渉力：中～高中～高
3.4.5 供給者の交渉力：中～高
3.5 SWOT分析
3.6 PEST分析
3.7 パンデミックの中で製薬業界はどのように適応したか？
3.8 なぜCROsはM&Aを採用するのか？

4 医薬品開発業務受託機関（CROs）市場分析：サービス別
4.1 主要な調査結果
4.2 サービスセグメント市場魅力度指数
4.3 サービス別開発業務受託機関（CROs）市場規模推定と予測
4.4 前臨床
4.4.1 2023〜2033年の地域別市場規模（US$ Billion）
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 臨床
4.5.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.2 地域別市場シェア、2023年・2033年(%)
4.5.3 フェーズI
4.5.3.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.3.2 地域別市場シェア、2023年・2033年(%)
4.5.4 フェーズII
4.5.4.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.4.2 地域別市場シェア、2023年・2033年(%)
4.5.5 フェーズ III
4.5.5.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.5.2 地域別市場シェア、2023年・2033年(%)
4.5.6 フェーズ Ⅳ
4.5.6.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.6.2 地域別市場シェア、2023年・2033年(%)
4.6 臨床検査サービス
4.6.1 2023～2033年の地域別市場規模（US$ Billion）
4.6.2 地域別市場シェア、2023年・2033年(%)
4.7 コンサルティングサービス
4.7.1 2023～2033年の地域別市場規模（US$ Billion）
4.7.2 地域別市場シェア、2023年・2033年(%)
4.8 データマネジメントサービス
4.8.1 2023〜2033年の地域別市場規模（US$ Billion）
4.8.2 地域別市場シェア、2023年・2033年(%)

5 医薬品開発業務受託機関（CROs）市場：企業規模別、2023年〜2033年
5.1 主要調査結果
5.2 企業規模セグメント市場魅力度指数
5.3 医薬品開発業務受託機関（CROs）市場：企業規模別
5.4 大手製薬企業・バイオテクノロジー企業
5.4.1 2023〜2033年の地域別市場規模（US$ Billion）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 中堅医薬品・バイオテクノロジー企業
5.5.1 2023〜2033年の地域別市場規模（US$ Billion）
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 中小医薬品・バイオテクノロジー企業
5.6.1 2023年～2033年の地域別市場規模（US$ Billion）
5.6.2 地域別市場シェア、2023年・2033年(%)

6 医薬品開発業務受託機関（CROs）市場：医薬品タイプ別、2023年〜2033年
6.1 主要調査結果
6.2 薬剤タイプ別セグメント市場魅力度指数
6.3 医薬品タイプ別CROs市場規模推定と予測
6.4 低分子
6.4.1 2023〜2033年の地域別市場規模（US$ Billion）
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 大分子
6.5.1 2023〜2033年の地域別市場規模（US$ Billion）
6.5.2 地域別市場シェア、2023年・2033年(%)

7 医薬品開発業務受託機関（CROs）市場：治療領域別、2023年〜2033年
7.1 主要調査結果
7.2 治療領域セグメント市場魅力度指数
7.3 治療領域別CROs市場規模推定と予測
7.4 がん領域
7.4.1 2023〜2033年の地域別市場規模（US$ Billion）
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 中枢神経系
7.5.1 2023〜2033年の地域別市場規模（US$ Billion）
7.5.2 地域別市場シェア、2023年・2033年(%)
7.6 循環器
7.6.1 2023〜2033年の地域別市場規模（US$ Billion）
7.6.2 地域別市場シェア、2023年・2033年(%)
7.7 感染症
7.7.1 2023〜2033年の地域別市場規模（US$ Billion）
7.7.2 地域別市場シェア、2023年・2033年(%)
7.8 代謝性
7.8.1 2023〜2033年の地域別市場規模（US$ Billion）
7.8.2 地域別市場シェア、2023年・2033年(%)
7.9 その他の治療領域
7.9.1 2023〜2033年の地域別市場規模（US$ Billion）
7.9.2 地域別市場シェア、2023年・2033年(%)

8 医薬品開発業務受託機関（CROs）市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測

9 北米の医薬品開発業務受託機関（CROs）市場分析
9.1 主要な調査結果
9.2 北米の医薬品開発業務受託機関（CROs）市場魅力度指数
9.3 北米の医薬品開発業務受託機関（CROs）市場の国別市場規模、2023年、2028年、2033年 (US$ Billion)
9.4 北米の医薬品開発業務受託機関（CROs）市場規模推定と予測：国別
9.5 北米の医薬品開発業務受託機関（CROs）市場規模推定と予測：サービス別
9.6 北米の医薬品開発業務受託機関（CROs）市場規模推定と予測：企業規模別
9.7 北米の医薬品開発業務受託機関（CROs）市場規模推定と予測：医薬品タイプ別
9.8 北米の医薬品開発業務受託機関（CROs）市場規模推定と予測：治療領域別
9.9 米国の医薬品開発業務受託機関（CROs）市場分析
9.10 カナダの医薬品開発業務受託機関（CROs）市場分析

10 欧州の医薬品開発業務受託機関（CRO）市場、2023-2033年
10.1 主要な調査結果
10.2 欧州CRO市場魅力度指数
10.3 欧州の医薬品開発業務受託機関（CROs）市場：国別、2023年、2028年、2033年 (US$ Billion)
10.4 欧州の医薬品開発業務受託機関（CROs）市場規模推定と予測：国別
10.5 欧州の医薬品開発業務受託機関（CROs）市場規模推定と予測：サービス別
10.6 欧州の医薬品開発業務受託機関（CROs）市場規模推定と予測：企業規模別
10.7 欧州の医薬品開発業務受託機関（CROs）市場規模推定と予測：医薬品タイプ別
10.8 欧州の医薬品開発業務受託機関（CROs）市場規模推定と予測：治療領域別
10.9 ドイツの医薬品開発業務受託機関（CROs）市場分析
10.10 英国の医薬品開発業務受託機関（CROs）市場分析
10.11 フランスの医薬品開発業務受託機関（CROs）市場分析
10.12 イタリアの医薬品開発業務受託機関（CROs）市場分析
10.13 スペインの医薬品開発業務受託機関（CROs）市場分析
10.14 スイスの医薬品開発業務受託機関（CROs）市場分析
10.15 オランダの医薬品開発業務受託機関（CROs）市場分析
10.16 その他の地域の医薬品開発業務受託機関（CROs）市場分析

11 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場魅力度指数
11.3 アジア太平洋地域の医薬品開発業務受託機関（CROs）国別市場、2023年、2028年、2033年 (US$ Billion)
11.4 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場規模推定と予測：国別
11.5 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場規模推定と予測：サービス別
11.6 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場規模推定と予測：企業規模別
11.7 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場規模推定と予測：医薬品タイプ別
11.8 アジア太平洋地域の医薬品開発業務受託機関（CROs）市場規模推定と予測：治療領域別
11.9 日本の医薬品開発業務受託機関（CROs）市場分析
11.10 中国の医薬品開発業務受託機関（CROs）市場分析
11.11 インドの医薬品開発業務受託機関（CROs）市場分析
11.12 オーストラリアの医薬品開発業務受託機関（CROs）市場分析
11.13 韓国の医薬品開発業務受託機関（CROs）市場分析
11.14 シンガポールの医薬品開発業務受託機関（CROs）市場分析
11.15 その他のアジア太平洋地域の医薬品開発業務受託機関（CROs）市場分析

12 ラテンアメリカの医薬品開発業務受託機関（CROs）市場分析
12.1 主要な調査結果
12.2 ラテンアメリカの医薬品開発業務受託機関（CROs）市場魅力度指数
12.3 ラテンアメリカの医薬品開発業務受託機関（CROs）国別市場、2023年、2028年、2033年 (US$ Billion)
12.4 ラテンアメリカの医薬品開発業務受託機関（CROs）市場規模推定と予測：国別
12.5 ラテンアメリカの医薬品開発業務受託機関（CROs）市場規模推定と予測：サービス別
12.6 ラテンアメリカの医薬品開発業務受託機関（CROs）市場規模推定と予測：企業規模別
12.7 ラテンアメリカの医薬品開発業務受託機関（CROs）市場規模推定と予測：医薬品タイプ別
12.8 ラテンアメリカの医薬品開発業務受託機関（CROs）市場規模推定と予測：治療領域別
12.9 ブラジルの医薬品開発業務受託機関（CROs）市場分析
12.10 メキシコの医薬品開発業務受託機関（CROs）市場分析
12.11 アルゼンチンの医薬品開発業務受託機関（CROs）市場分析
12.12 その他のラテンアメリカの医薬品開発業務受託機関（CROs）市場分析

13 MEAの医薬品開発業務受託機関（CROs）市場分析
13.1 主要な調査結果
13.2 MEAの医薬品開発業務受託機関（CROs）市場魅力度指数
13.3 MEAの医薬品開発業務受託機関（CROs）国別市場、2023年、2028年、2033年 (US$ Billion)
13.4 MEAの医薬品開発業務受託機関（CROs）市場規模推定と予測：国別
13.5 MEAの医薬品開発業務受託機関（CROs）市場規模推定と予測：サービス別
13.6 MEAの医薬品開発業務受託機関（CROs）市場規模推定と予測：企業規模別
13.7 MEAの医薬品開発業務受託機関（CROs）市場規模推定と予測：医薬品タイプ別
13.8 MEAの医薬品開発業務受託機関（CROs）市場規模推定と予測：治療領域別
13.9 GCCの医薬品開発業務受託機関（CROs）市場分析
13.10 南アフリカの医薬品開発業務受託機関（CROs）市場分析
13.11 エジプトの医薬品開発業務受託機関（CROs）市場分析
13.12 その他のMEAの医薬品開発業務受託機関（CROs）市場分析

14 主要企業のプロファイル
14.1 競争環境、2022年
14.2 Charles River Laboratories
14.2.1 会社概要
14.2.2 会社概要
14.2.3 財務分析
14.2.3.1 純収入、2018年～2022年
14.2.3.2 セグメント市場シェア、2022年
14.2.3.3 地域別市場シェア、2022年
14.2.4 サービスベンチマーク
14.2.5 戦略的展望
14.3 CMIC HOLDINGS Co., Ltd.
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2018-2022年
14.3.3.2 セグメント市場シェア、2022年
14.3.4 サービスベンチマーク
14.3.5 戦略的展望
14.4 Caidya
14.4.1 会社概要
14.4.2 会社概要
14.4.3 サービス・ベンチマーク
14.4.4 戦略的展望
14.5 ICON plc
14.5.1 会社概要
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収入、2018-2022年
14.5.3.2 地域市場シェア、2022年
14.5.4 サービスベンチマーク
14.5.5 戦略的展望
14.6 IQVIA Inc.
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収入、2018-2022年
14.6.3.2 セグメント市場シェア、2022年
14.6.3.3 地域市場シェア、2022年
14.6.4 サービスベンチマーク
14.6.5 戦略的展望
14.7 Labcorp Drug Development
14.7.1 会社概要
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収入、2018-2022年
14.7.3.2 セグメント市場シェア、2022年
14.7.3.3 地域市場シェア、2022年
14.7.4 サービスベンチマーク
14.7.5 戦略的展望
14.8 Medpace
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収入、2018-2022年
14.8.3.2 セグメント市場シェア、2022年
14.8.4 サービスベンチマーク
14.9 Parexel International (MA) Corporation
14.9.1 会社概要
14.9.2 会社概要
14.9.3 サービス・ベンチマーク
14.9.4 戦略的展望
14.10 Thermo Fisher Scientific Inc. (PPD)
14.10.1 会社概要
14.10.2 会社概要
14.10.3 財務分析
14.10.3.1 純収入、2018-2022年
14.10.3.2 R＆D、2018年～2022年
14.10.3.3 セグメント市場シェア、2022年
14.10.3.4 地域市場シェア、2022年
14.10.4 サービスベンチマーク
14.10.5 戦略的展望
14.11 Syneos Health
14.11.1 会社概要
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収入、2018-2022年
14.11.3.2 セグメント市場シェア、2022年
14.11.3.3 地域市場シェア、2022年
14.11.4 サービスベンチマーク
14.11.5 戦略的展望
14.12 Worldwide Clinical Trials
14.12.1 企業スナップショット
14.12.2 企業概要
14.12.3 サービス・ベンチマーク
14.12.4 戦略的展望
14.13 Wuxi AppTec
14.13.1 会社概要
14.13.2 会社概要
14.13.3 財務分析
14.13.3.1 純収入、2018-2022年
14.13.3.2 セグメント市場シェア、2022年
14.13.3.3 地域別市場シェア、2022年
14.13.4 サービスベンチマーク
14.13.5 戦略的展望
14.14 Eurofins Scientific
14.14.1 会社概要
14.14.2 会社概要
14.14.3 財務分析
14.14.3.1 純収入、2018-2022年
14.14.3.2 セグメント市場シェア、2022年
14.14.3.3 地域別市場シェア、2022年
14.14.4 サービスベンチマーク
14.14.5 戦略的展望
14.15 Evotec SE
14.15.1 会社概要
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純収入、2018-2022年
14.15.3.2 R＆D、2018年～2022年
14.15.3.3 地域市場シェア、2022年
14.15.4 サービスベンチマーク
14.15.5 戦略的展望
14.16 Allucent
14.16.1 会社概要
14.16.2 会社概要
14.16.3 サービス・ベンチマーク
14.16.4 戦略的展望
14.17 Syngene International
14.17.1 会社概要
14.17.2 会社概要
14.17.3 財務分析
14.17.3.1 純収入、2018年～2022年
14.17.3.2 地域市場シェア、2022年
14.17.4 サービスベンチマーク
14.17.5 戦略的展望
14.18 Anthem Biosciences Private Limited
14.18.1 会社概要
14.18.2 会社概要
14.18.3 サービス・ベンチマーク
14.19 The Emmes Company, LLC
14.19.1 会社概要
14.19.2 会社概要
14.19.3 サービス・ベンチマーク
14.19.4 戦略的展望
14.20 Bio-Techne
14.20.1 会社概要
14.20.2 会社概要
14.20.3 財務分析
14.20.3.1 純収入、2018年～2022年
14.20.3.2 R＆D、2018年～2022年
14.20.3.3 セグメント市場シェア、2022年
14.20.3.4 地域市場シェア、2022年
14.20.4 サービスベンチマーク
14.20.5 戦略的展望
14.21 Inotiv
14.21.1 会社概要
14.21.2 会社概要
14.21.3 財務分析
14.21.3.1 純収入、2018年～2022年
14.21.3.2 セグメント市場シェア、2022年
14.21.3.3 地域市場シェア、2022年
14.21.4 サービスベンチマーク
14.21.5 戦略的展望
14.22 Frontage Labs.
14.22.1 会社概要
14.22.2 会社概要
14.22.3 財務分析
14.22.3.1 純収入、2018-2022年
14.22.3.2 R＆D、2018-2022年
14.22.3.3 セグメント市場シェア、2022年
14.22.3.4 地域市場シェア、2022年
14.22.4 サービスベンチマーク
14.22.5 戦略的展望

15 結論と提言
15.1 Visiongainの結論
15.2 市場プレイヤーへの提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 Contract Research Organisations (CROs) Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 Clinical Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 Phase I Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 Phase II Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Phase III Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Oncology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 CNS Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Infectious Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 56 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 57 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 58 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 59 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 60 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 61 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 68 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 69 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 70 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 72 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 73 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 74 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 75 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 77 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 78 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 79 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 80 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Charles River Laboratories: Service Benchmarking
Table 83 Charles River Laboratories: Strategic Outlook
Table 84 CMIC HOLDINGS Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 CMIC HOLDINGS Co., Ltd.: Service Benchmarking
Table 86 CMIC HOLDINGS Co., Ltd.: Strategic Outlook
Table 87 Caidya: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Caidya: Service Benchmarking
Table 89 Caidya: Strategic Outlook
Table 90 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 ICON plc: Service Benchmarking
Table 92 ICON plc: Strategic Outlook
Table 93 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 IQVIA Inc.: Service Benchmarking
Table 95 IQVIA Inc.: Strategic Outlook
Table 96 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Labcorp Drug Development: Service Benchmarking
Table 98 Labcorp Drug Development: Strategic Outlook
Table 99 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Medpace: Service Benchmarking
Table 101 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Parexel International (MA) Corporation.: Service Benchmarking
Table 103 Parexel International (MA) Corporation.: Strategic Outlook
Table 104 Thermo Fisher Scientific Inc. (PPD): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Thermo Fisher Scientific Inc. (PPD): Service Benchmarking
Table 106 Thermo Fisher Scientific Inc. (PPD): Strategic Outlook
Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Syneos Health: Service Benchmarking
Table 109 Syneos Health: Strategic Outlook
Table 110 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Worldwide Clinical Trials: Service Benchmarking
Table 112 Worldwide Clinical Trials: Strategic Outlook
Table 113 Wuxi AppTec : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Wuxi AppTec : Service Benchmarking
Table 115 Wuxi AppTec : Strategic Outlook
Table 116 Eurofins Scientific.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Eurofins Scientific.: Service Benchmarking
Table 118 Eurofins Scientific.: Strategic Outlook
Table 119 Evotec SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Evotec SE: Service Benchmarking
Table 121 Evotec SE: Strategic Outlook
Table 122 Allucent : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Allucent: Service Benchmarking
Table 124 Allucent: Strategic Outlook
Table 125 Syngene International : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Syngene International: Service Benchmarking
Table 127 Syngene International: Strategic Outlook
Table 128 Anthem Biosciences Private Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Anthem Biosciences Private Limited: Service Benchmarking
Table 130 The Emmes Company, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 The Emmes Company, LLC: Service Benchmarking
Table 132 The Emmes Company, LLC: Strategic Outlook
Table 133 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Bio-Techne: Service Benchmarking
Table 135 Bio-Techne: Strategic Outlook
Table 136 Inotiv: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Inotiv: Service Benchmarking
Table 138 Inotiv: Strategic Outlook
Table 139 Frontage Labs.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Frontage Labs.: Service Benchmarking
Table 141 Frontage Labs.: Strategic Outlook

図の一覧
Figure 1 Contract Research Organisations (CROs) Market Segmentation
Figure 2 Contract Research Organisations (CROs) Market Attractiveness Index by Region
Figure 3 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
Figure 4 Contract Research Organisations (CROs) Market by Company Size: Market Attractiveness Index
Figure 5 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 6 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 7 Contract Research Organisations (CROs) Market: Market Dynamics
Figure 8 Number of Clinical Trials Listed in the WHO International Clinical Trials Registry Platform, by Region, 2020-2022
Figure 9 R&D Spending of Large Pharmaceutical Companies in $ Billion, 2022
Figure 10 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 11 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 12 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 13 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 14 Contract Research Organisations (CROs) Market: Porter’s Five Forces Analysis
Figure 15 Contract Research Organisations (CROs) Market: SWOT Analysis
Figure 16 Contract Research Organisations (CROs) Market: PEST Analysis
Figure 17 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
Figure 18 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
Figure 19 Contract Research Organisations (CROs) Market Share Forecast by Service, 2023, 2028, 2033 (%)
Figure 20 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 21 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Clinical Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 23 Clinical Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Phase I Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 25 Phase I Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Phase II Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 27 Phase II Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase III Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 29 Phase III Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 31 Phase IV Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 33 Laboratory Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 35 Consulting Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 37 Data Management Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Contract Research Organisations (CROs) Market by Application: Market Attractiveness Index
Figure 39 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion)
Figure 40 Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023, 2028, 2033 (%)
Figure 41 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 42 Large Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 44 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 46 Small Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 48 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 49 Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
Figure 50 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 51 Small Molecules Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 53 Large Molecules Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 55 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 56 Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 57 Oncology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 58 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 CNS Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 60 CNS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 62 Cardiology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Infectious Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 64 Infectious Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 66 Metabolic Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 68 Other Therapeutic Area Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Contract Research Organisations (CROs) Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 70 Contract Research Organisations (CROs) Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 71 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %)
Figure 72 North America Contract Research Organisations (CROs) Market Attractiveness Index
Figure 73 North America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 74 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 75 North America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
Figure 77 North America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 78 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR %)
Figure 79 North America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 80 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 81 North America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 82 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR %)
Figure 83 North America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 84 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 85 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 86 Europe Contract Research Organisations (CROs) Market Attractiveness Index
Figure 87 Europe Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 88 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 89 Europe Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 90 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 91 Europe Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 92 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 93 Europe Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 94 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 95 Europe Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033(%)
Figure 96 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 97 Europe Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033(%)
Figure 98 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 99 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 100 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 104 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 105 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 106 Asia Pacific Contract Research Organisations (CROs) Market Attractiveness Index
Figure 107 Asia Pacific Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 108 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 109 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 110 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 111 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 112 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 113 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 114 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 115 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 116 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 117 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 118 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 119 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 120 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 121 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 122 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 123 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 124 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 125 Latin America Contract Research Organisations (CROs) Market Attractiveness Index
Figure 126 Latin America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 127 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 128 Latin America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 129 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 130 Latin America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 131 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 132 Latin America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 133 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 134 Latin America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 135 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 136 Latin America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 137 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 138 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 139 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 141 MEA Contract Research Organisations (CROs) Market Attractiveness Index
Figure 142 MEA Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 143 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 144 MEA Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 145 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 146 MEA Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 147 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 148 MEA Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 149 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 150 MEA Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 151 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 152 MEA Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 153 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 154 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 155 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 156 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 157 Contract Research Organisations (CROs) Market: Company Share/Ranking, 2022
Figure 158 Charles River Laboratories: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 159 Charles River Laboratories: Segment Market Shares, 2022
Figure 160 Charles River Laboratories: Regional Market Shares, 2022
Figure 161 CMIC HOLDINGS Co., Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 162 CMIC HOLDINGS Co., Ltd.: Segment Market Shares -2022
Figure 163 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 164 ICON plc: Regional Market Shares, 2022
Figure 165 IQVIA Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 166 IQVIA Inc.: Segment Market Shares, 2022
Figure 167 IQVIA Inc.: Regional Market Shares, 2022
Figure 168 Labcorp Drug Development: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 169 Labcorp Drug Development: Segment Market Shares, 2022
Figure 170 Labcorp Drug Development: Regional Market Shares, 2022
Figure 171 Medpace: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 172 Medpace: Segment Market Shares, 2022
Figure 173 Thermo Fisher Scientific Inc. (PPD): Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 174 Thermo Fisher Scientific Inc. (PPD): R&D, 2018-2022(US$ Million, AGR %)
Figure 175 Thermo Fisher Scientific Inc. (PPD): Segment Market Shares, 2022
Figure 176 Thermo Fisher Scientific Inc. (PPD): Regional Market Shares, 2022
Figure 177 Syneos Health.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 178 Syneos Health.: Segment Market Shares, 2022
Figure 179 Syneos Health.: Regional Market Shares, 2022
Figure 180 Wuxi AppTec: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 181 Wuxi AppTec : Segment Market Shares, 2022
Figure 182 Wuxi AppTec .: Regional Market Shares, 2022
Figure 183 Eurofins Scientific.: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 184 Eurofins Scientific.: Segment Market Shares, 2022
Figure 185 Eurofins Scientific.: Regional Market Shares, 2022
Figure 186 Evotec SE: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 187 Evotec SE: R&D, 2018-2022 (US$ Million, AGR %)
Figure 188 Evotec SE: Regional Market Shares, 2022
Figure 189 Syngene International: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 190 Syngene International: Regional Market Shares, 2022
Figure 191 Bio-Techne: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 192 Bio-Techne: R&D, 2018-2022 (US$ Million, AGR %)
Figure 193 Bio-Techne: Segment Market Shares, 2022
Figure 194 Bio-Techne: Regional Market Shares, 2022
Figure 195 Inotiv: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 196 Inotiv: Segment Market Shares, 2022
Figure 197 Inotiv: Regional Market Shares, 2022
Figure 198 Frontage Labs. : Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 199 Frontage Labs.: R & D, 2018-2022 (US$ Million, AGR %)
Figure 200 Frontage Labs.: Segment Market Shares, 2022
Figure 201 Frontage Labs.: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The Contract Research Organisations (CROs) Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The market for biopharmaceuticals is rising, there is an increase in the need for healthcare due to an ageing population, and the biotech, pharmaceutical, and medical device industries are expanding to fulfil this demand. As a result, the demand for effective clinical studies has increased in order to ensure the efficacy and safety of products. Worldwide, there are around 266 thousand open clinical trials ongoing. More than 105,000 open clinical investigations are now being conducted just in the United States.

The burden of uncommon diseases is increasing internationally, which has led to an increase and innovation in the creation of medicines. While it is still true that only a small portion of terminal rare diseases receive their initial treatment each year and that over 90% of these diseases await therapy approval. In 2021, the CDC reported that 475 million individuals, or nearly 10% of the world’s population, were thought to be living with a rare disease. 15.2 million Individuals are predicted to receive clinical genetic testing for a rare disease during the course of the next five years. A rising number of nations are putting in place government programs to assist people with rare illnesses.

Intellectual Property Issues Likely to Challenge Industry Growth
Intellectual property is one of the key barriers to outsourcing clinical trials, which might restrict the expansion of contract research organisations’ markets. Because copyrighted products make up the majority of therapeutic candidates, a contract research organisation may increase the danger of data leaks.

Additionally, pharmaceutical companies that develop novel medicines are expected to provide clinical data about safety and efficacy to the relevant governmental and regulatory bodies in order for their treatments to be approved. As a result, the guidelines for pre- and post-grant disagreement as well as issues pertaining to the patent are quite strict. However, it improves the efficiency of inspection and has assisted in the cancellation of patents. It is crucial to focus more emphasis on clinical trial agreements since the government thoroughly evaluates clinical trial-related issues as well. However, these issues harm the CRO’s reputation and may stop the sector for contract research organisations from expanding.

What Questions Should You Ask Before Buying a Market Research Report?
• How is the contract research organisations (CROs) market evolving?
• What is driving and restraining the contract research organisations (CROs) market?
• How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each contract research organisations (CROs) submarket develop from 2022 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading contract research organisations (CROs) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the contract research organisations (CROs) projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of contract research organisations (CROs) projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the contract research organisations (CROs) market?
• Where is the contract research organisations (CROs) market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Contract Research Organisations (CROs) market today, and over the next 10 years:
• Our 353-page report provides 141 tables, 201 charts, and graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Contract Research Organisations (CROs) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Contract Research Organisations (CROs) prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Service
• Preclinical
• Clinical
– Phase I
– Phase II
– Phase III
– Phase IV
• Laboratory Services
• Consulting Services
• Data Management Services

Company Size
• Large Pharma & Biotech Companies
• Mid-sized Pharma & Biotech Companies
• Small Pharma & Biotech Companies

Drug Type
• Small Molecules
• Large Molecules

Therapeutic Area
• Oncology
• CNS
• Cardiology
• Infectious
• Metabolic
• Other Therapeutic Area

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Switzerland
• Netherlands
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA
• GCC
• South Africa
• Egypt
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Contract Research Organisations (CROs) Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Allucent
• Anthem Biosciences Private Limited
• Bio-Techne
• Charles River Laboratories
• Caidya
• CMIC HOLDINGS Co., Ltd.
• Eurofins Scientific
• Evotec SE
• Frontage Labs
• ICON plc
• Inotiv
• IQVIA Inc.
• Labcorp Drug Development
• Medpace
• Parexel International (MA) Corporation
• PPD (Thermo Fisher Scientific Inc.)
• Syneos Health
• Syngene International Limited
• The Emmes Company, LLC
• Worldwide Clinical Trials
• Wuxi AppTec

Overall world revenue for Contract Research Organisations (CROs) Market, 2023 to 2033 in terms of value the market will surpass US$68 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Contract Research Organisations (CROs) Market, 2023 to 2033 report help you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Contract Research Organisations (CROs) Market, 2023 to 2033, with forecasts for services, company size, drug type, and therapeutic area, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 25 key national markets – See forecasts for the Contract Research Organisations (CROs) Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 21 of the major companies involved in the Contract Research Organisations (CROs) Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Contract Research Organisations (CROs) Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Contract Research Organisations (CROs) Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Clinical Trials Globally
3.2.1.2 Growing Disease Burden Globally to Fuel CROs Market Growth
3.2.1.3 Rising R&D Investments by Pharmaceutical and Biotech Companies to Boost CROs Market Growth
3.2.1.4 Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
3.2.1.5 High Cost of In-house Drug Development
3.2.2 Market Restraining Factors
3.2.2.1 Intellectual Property Issues May Hamper CROs Industry Growth
3.2.2.2 Shortage of Skilled Labour Post COVID-19 Hampering CRO Industry
3.2.3 Market Opportunities
3.2.3.1 Applications of Artificial Intelligence Could Lead to Faster, Safer and Significantly Less Expensive Clinical Trials
3.2.3.2 Increasing Demand for Biological Therapies to Offer Lucrative Growth Prospects for CROs
3.2.3.3 Growth in Nuclear Medicine Sector
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Competitive Rivalry: High
3.4.2 Threat of New Entrants: Low to Medium
3.4.3 Threat of Substitutes: Low to Medium
3.4.4 Bargaining Power of Buyers: Medium to High
3.4.5 Bargaining Power of Suppliers: Medium to High
3.5 SWOT Analysis
3.6 PEST Analysis
3.7 How has the Pharmaceutical Industry Adapted Amidst the Pandemic?
3.8 Why are CROs Adopting Mergers & Acquisitions?

4 Contract Research Organisations (CROs) Market Analysis by Services
4.1 Key Findings
4.2 Services Segment: Market Attractiveness Index
4.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
4.4 Preclinical
4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Clinical
4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Phase I
4.5.3.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Phase II
4.5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.5.5 Phase III
4.5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.6 Phase IV
4.5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.6.2 Market Share by Region, 2023 & 2033 (%)
4.6 Laboratory Services
4.6.1 Market Size by Region, 2023-2033 (US$ Billion)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Consulting Services
4.7.1 Market Size by Region, 2023-2033 (US$ Billion)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Data Management Services
4.8.1 Market Size by Region, 2023-2033 (US$ Billion)
4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Contract Research Organisations (CROs) Market, by Company Size, 2023-2033
5.1 Key Findings
5.2 Company Size Segment: Market Attractiveness Index
5.3 Contract Research Organisations (CROs) Market, by Company Size
5.4 Large Pharma & Biotech Companies
5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Mid-sized Pharma & Biotech Companies
5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Small Pharma & Biotech Companies
5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Contract Research Organisations (CROs) Market, by Drug Type, 2023-2033
6.1 Key Findings
6.2 Drug Type Segment: Market Attractiveness Index
6.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
6.4 Small Molecules
6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Large Molecules
6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Contract Research Organisations (CROs) Market, by Therapeutic Area, 2023-2033
7.1 Key Findings
7.2 Therapeutic Area Segment: Market Attractiveness Index
7.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 CNS
7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Cardiology
7.6.1 Market Size by Region, 2023-2033 (US$ Billion)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Infectious
7.7.1 Market Size by Region, 2023-2033 (US$ Billion)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Metabolic
7.8.1 Market Size by Region, 2023-2033 (US$ Billion)
7.8.2 Market Share by Region, 2023 & 2033 (%)
7.9 Other Therapeutic Area
7.9.1 Market Size by Region, 2023-2033 (US$ Billion)
7.9.2 Market Share by Region, 2023 & 2033 (%)

8 Contract Research Organisations (CROs) Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Contract Research Organisations (CROs) Market Analysis
9.1 Key Findings
9.2 North America Contract Research Organisations (CROs) Market Attractiveness Index
9.3 North America Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
9.5 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
9.6 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
9.7 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
9.8 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
9.9 U.S. Contract Research Organisations (CROs) Market Analysis
9.10 Canada Contract Research Organisations (CROs) Market Analysis

10 Europe Contract Research Organisations (CROs) Market, 2023-2033
10.1 Key Findings
10.2 Europe Contract Research Organisations (CROs) Market Attractiveness Index
10.3 Europe Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
10.5 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
10.6 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
10.7 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
10.8 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
10.9 Germany Contract Research Organisations (CROs) Market Analysis
10.10 UK Contract Research Organisations (CROs) Market Analysis
10.11 France Contract Research Organisations (CROs) Market Analysis
10.12 Italy Contract Research Organisations (CROs) Market Analysis
10.13 Spain Contract Research Organisations (CROs) Market Analysis
10.14 Switzerland Contract Research Organisations (CROs) Market Analysis
10.15 Netherlands Contract Research Organisations (CROs) Market Analysis
10.16 Rest of Europe Contract Research Organisations (CROs) Market Analysis

11 Asia Pacific Contract Research Organisations (CROs) Market Analysis
11.1 Key Findings
11.2 Asia Pacific Contract Research Organisations (CROs) Market Attractiveness Index
11.3 Asia Pacific Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
11.5 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
11.6 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
11.7 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
11.8 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
11.9 Japan Contract Research Organisations (CROs) Market Analysis
11.10 China Contract Research Organisations (CROs) Market Analysis
11.11 India Contract Research Organisations (CROs) Market Analysis
11.12 Australia Contract Research Organisations (CROs) Market Analysis
11.13 South Korea Contract Research Organisations (CROs) Market Analysis
11.14 Singapore Contract Research Organisations (CROs) Market Analysis
11.15 Rest of Asia Pacific Contract Research Organisations (CROs) Market Analysis

12 Latin America Contract Research Organisations (CROs) Market Analysis
12.1 Key Findings
12.2 Latin America Contract Research Organisations (CROs) Market Attractiveness Index
12.3 Latin America Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
12.4 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
12.5 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
12.6 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
12.7 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
12.8 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
12.9 Brazil Contract Research Organisations (CROs) Market Analysis
12.10 Mexico Contract Research Organisations (CROs) Market Analysis
12.11 Argentina Contract Research Organisations (CROs) Market Analysis
12.12 Rest of Latin America Contract Research Organisations (CROs) Market Analysis

13 MEA Contract Research Organisations (CROs) Market Analysis
13.1 Key Findings
13.2 MEA Contract Research Organisations (CROs) Market Attractiveness Index
13.3 MEA Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
13.4 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
13.5 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
13.6 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
13.7 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
13.8 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
13.9 GCC Contract Research Organisations (CROs) Market Analysis
13.10 South Africa Contract Research Organisations (CROs) Market Analysis
13.11 Egypt Contract Research Organisations (CROs) Market Analysis
13.12 Rest of MEA Contract Research Organisations (CROs) Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2018-2022
14.2.3.2 Segment Market Shares, 2022
14.2.3.3 Regional Market Shares, 2022
14.2.4 Service Benchmarking
14.2.5 Strategic Outlook
14.3 CMIC HOLDINGS Co., Ltd.
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2018-2022
14.3.3.2 Segment Market Shares, 2022
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Caidya
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Service Benchmarking
14.4.4 Strategic Outlook
14.5 ICON plc
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2018-2022
14.5.3.2 Regional Market Shares, 2022
14.5.4 Service Benchmarking
14.5.5 Strategic Outlook
14.6 IQVIA Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2022
14.6.3.2 Segment Market Shares, 2022
14.6.3.3 Regional Market Shares, 2022
14.6.4 Service Benchmarking
14.6.5 Strategic Outlook
14.7 Labcorp Drug Development
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2018-2022
14.7.3.2 Segment Market Shares, 2022
14.7.3.3 Regional Market Shares, 2022
14.7.4 Service Benchmarking
14.7.5 Strategic Outlook
14.8 Medpace
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2018-2022
14.8.3.2 Segment Market Shares, 2022
14.8.4 Service Benchmarking
14.9 Parexel International (MA) Corporation
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Service Benchmarking
14.9.4 Strategic Outlook
14.10 Thermo Fisher Scientific Inc. (PPD)
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2018-2022
14.10.3.2 R&D, 2018-2022
14.10.3.3 Segment Market Shares, 2022
14.10.3.4 Regional Market Shares, 2022
14.10.4 Service Benchmarking
14.10.5 Strategic Outlook
14.11 Syneos Health
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2018-2022
14.11.3.2 Segment Market Shares, 2022
14.11.3.3 Regional Market Shares, 2022
14.11.4 Service Benchmarking
14.11.5 Strategic Outlook
14.12 Worldwide Clinical Trials
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Service Benchmarking
14.12.4 Strategic Outlook
14.13 Wuxi AppTec
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2018-2022
14.13.3.2 Segment Market Shares, 2022
14.13.3.3 Regional Market Shares, 2022
14.13.4 Service Benchmarking
14.13.5 Strategic Outlook
14.14 Eurofins Scientific
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2018-2022
14.14.3.2 Segment Market Shares, 2022
14.14.3.3 Regional Market Shares, 2022
14.14.4 Service Benchmarking
14.14.5 Strategic Outlook
14.15 Evotec SE
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2018-2022
14.15.3.2 R&D, 2018-2022
14.15.3.3 Regional Market Shares, 2022
14.15.4 Service Benchmarking
14.15.5 Strategic Outlook
14.16 Allucent
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Service Benchmarking
14.16.4 Strategic Outlook
14.17 Syngene International
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2018-2022
14.17.3.2 Regional Market Shares, 2022
14.17.4 Service Benchmarking
14.17.5 Strategic Outlook
14.18 Anthem Biosciences Private Limited
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Service Benchmarking
14.19 The Emmes Company, LLC
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Service Benchmarking
14.19.4 Strategic Outlook
14.20 Bio-Techne
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis
14.20.3.1 Net Revenue, 2018-2022
14.20.3.2 R&D, 2018-2022
14.20.3.3 Segment Market Shares, 2022
14.20.3.4 Regional Market Shares, 2022
14.20.4 Service Benchmarking
14.20.5 Strategic Outlook
14.21 Inotiv
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Financial Analysis
14.21.3.1 Net Revenue, 2018-2022
14.21.3.2 Segment Market Shares, 2022
14.21.3.3 Regional Market Shares, 2022
14.21.4 Service Benchmarking
14.21.5 Strategic Outlook
14.22 Frontage Labs.
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Financial Analysis
14.22.3.1 Net Revenue, 2018-2022
14.22.3.2 R & D, 2018-2022
14.22.3.3 Segment Market Shares, 2022
14.22.3.4 Regional Market Shares, 2022
14.22.4 Service Benchmarking
14.22.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Contract Research Organisations (CROs) Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 Clinical Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 Phase I Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 Phase II Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Phase III Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Oncology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 CNS Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Infectious Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 56 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 57 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 58 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 59 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 60 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 61 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 68 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 69 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 70 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 72 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 73 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 74 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 75 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 77 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 78 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 79 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 80 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Charles River Laboratories: Service Benchmarking
Table 83 Charles River Laboratories: Strategic Outlook
Table 84 CMIC HOLDINGS Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 CMIC HOLDINGS Co., Ltd.: Service Benchmarking
Table 86 CMIC HOLDINGS Co., Ltd.: Strategic Outlook
Table 87 Caidya: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Caidya: Service Benchmarking
Table 89 Caidya: Strategic Outlook
Table 90 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 ICON plc: Service Benchmarking
Table 92 ICON plc: Strategic Outlook
Table 93 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 IQVIA Inc.: Service Benchmarking
Table 95 IQVIA Inc.: Strategic Outlook
Table 96 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Labcorp Drug Development: Service Benchmarking
Table 98 Labcorp Drug Development: Strategic Outlook
Table 99 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Medpace: Service Benchmarking
Table 101 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Parexel International (MA) Corporation.: Service Benchmarking
Table 103 Parexel International (MA) Corporation.: Strategic Outlook
Table 104 Thermo Fisher Scientific Inc. (PPD): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Thermo Fisher Scientific Inc. (PPD): Service Benchmarking
Table 106 Thermo Fisher Scientific Inc. (PPD): Strategic Outlook
Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Syneos Health: Service Benchmarking
Table 109 Syneos Health: Strategic Outlook
Table 110 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Worldwide Clinical Trials: Service Benchmarking
Table 112 Worldwide Clinical Trials: Strategic Outlook
Table 113 Wuxi AppTec : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Wuxi AppTec : Service Benchmarking
Table 115 Wuxi AppTec : Strategic Outlook
Table 116 Eurofins Scientific.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Eurofins Scientific.: Service Benchmarking
Table 118 Eurofins Scientific.: Strategic Outlook
Table 119 Evotec SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Evotec SE: Service Benchmarking
Table 121 Evotec SE: Strategic Outlook
Table 122 Allucent : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Allucent: Service Benchmarking
Table 124 Allucent: Strategic Outlook
Table 125 Syngene International : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Syngene International: Service Benchmarking
Table 127 Syngene International: Strategic Outlook
Table 128 Anthem Biosciences Private Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Anthem Biosciences Private Limited: Service Benchmarking
Table 130 The Emmes Company, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 The Emmes Company, LLC: Service Benchmarking
Table 132 The Emmes Company, LLC: Strategic Outlook
Table 133 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Bio-Techne: Service Benchmarking
Table 135 Bio-Techne: Strategic Outlook
Table 136 Inotiv: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Inotiv: Service Benchmarking
Table 138 Inotiv: Strategic Outlook
Table 139 Frontage Labs.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Frontage Labs.: Service Benchmarking
Table 141 Frontage Labs.: Strategic Outlook

List of Figures
Figure 1 Contract Research Organisations (CROs) Market Segmentation
Figure 2 Contract Research Organisations (CROs) Market Attractiveness Index by Region
Figure 3 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
Figure 4 Contract Research Organisations (CROs) Market by Company Size: Market Attractiveness Index
Figure 5 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 6 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 7 Contract Research Organisations (CROs) Market: Market Dynamics
Figure 8 Number of Clinical Trials Listed in the WHO International Clinical Trials Registry Platform, by Region, 2020-2022
Figure 9 R&D Spending of Large Pharmaceutical Companies in $ Billion, 2022
Figure 10 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 11 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 12 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 13 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 14 Contract Research Organisations (CROs) Market: Porter’s Five Forces Analysis
Figure 15 Contract Research Organisations (CROs) Market: SWOT Analysis
Figure 16 Contract Research Organisations (CROs) Market: PEST Analysis
Figure 17 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
Figure 18 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
Figure 19 Contract Research Organisations (CROs) Market Share Forecast by Service, 2023, 2028, 2033 (%)
Figure 20 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 21 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Clinical Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 23 Clinical Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Phase I Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 25 Phase I Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Phase II Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 27 Phase II Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase III Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 29 Phase III Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 31 Phase IV Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 33 Laboratory Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 35 Consulting Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 37 Data Management Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Contract Research Organisations (CROs) Market by Application: Market Attractiveness Index
Figure 39 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion)
Figure 40 Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023, 2028, 2033 (%)
Figure 41 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 42 Large Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 44 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 46 Small Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 48 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 49 Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
Figure 50 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 51 Small Molecules Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 53 Large Molecules Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 55 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 56 Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 57 Oncology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 58 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 CNS Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 60 CNS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 62 Cardiology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Infectious Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 64 Infectious Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 66 Metabolic Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 68 Other Therapeutic Area Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Contract Research Organisations (CROs) Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 70 Contract Research Organisations (CROs) Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 71 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %)
Figure 72 North America Contract Research Organisations (CROs) Market Attractiveness Index
Figure 73 North America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 74 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 75 North America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
Figure 77 North America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 78 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR %)
Figure 79 North America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 80 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 81 North America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 82 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR %)
Figure 83 North America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 84 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 85 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 86 Europe Contract Research Organisations (CROs) Market Attractiveness Index
Figure 87 Europe Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 88 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 89 Europe Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 90 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 91 Europe Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 92 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 93 Europe Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 94 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 95 Europe Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033(%)
Figure 96 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 97 Europe Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033(%)
Figure 98 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 99 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 100 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 104 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 105 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 106 Asia Pacific Contract Research Organisations (CROs) Market Attractiveness Index
Figure 107 Asia Pacific Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 108 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 109 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 110 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 111 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 112 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 113 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 114 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 115 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 116 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 117 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 118 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 119 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 120 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 121 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 122 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 123 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 124 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 125 Latin America Contract Research Organisations (CROs) Market Attractiveness Index
Figure 126 Latin America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 127 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 128 Latin America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 129 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 130 Latin America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 131 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 132 Latin America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 133 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 134 Latin America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 135 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 136 Latin America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 137 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 138 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 139 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 141 MEA Contract Research Organisations (CROs) Market Attractiveness Index
Figure 142 MEA Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 143 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 144 MEA Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
Figure 145 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
Figure 146 MEA Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
Figure 147 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
Figure 148 MEA Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 149 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
Figure 150 MEA Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 151 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
Figure 152 MEA Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 153 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 154 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 155 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 156 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 157 Contract Research Organisations (CROs) Market: Company Share/Ranking, 2022
Figure 158 Charles River Laboratories: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 159 Charles River Laboratories: Segment Market Shares, 2022
Figure 160 Charles River Laboratories: Regional Market Shares, 2022
Figure 161 CMIC HOLDINGS Co., Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 162 CMIC HOLDINGS Co., Ltd.: Segment Market Shares -2022
Figure 163 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 164 ICON plc: Regional Market Shares, 2022
Figure 165 IQVIA Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 166 IQVIA Inc.: Segment Market Shares, 2022
Figure 167 IQVIA Inc.: Regional Market Shares, 2022
Figure 168 Labcorp Drug Development: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 169 Labcorp Drug Development: Segment Market Shares, 2022
Figure 170 Labcorp Drug Development: Regional Market Shares, 2022
Figure 171 Medpace: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 172 Medpace: Segment Market Shares, 2022
Figure 173 Thermo Fisher Scientific Inc. (PPD): Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 174 Thermo Fisher Scientific Inc. (PPD): R&D, 2018-2022(US$ Million, AGR %)
Figure 175 Thermo Fisher Scientific Inc. (PPD): Segment Market Shares, 2022
Figure 176 Thermo Fisher Scientific Inc. (PPD): Regional Market Shares, 2022
Figure 177 Syneos Health.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 178 Syneos Health.: Segment Market Shares, 2022
Figure 179 Syneos Health.: Regional Market Shares, 2022
Figure 180 Wuxi AppTec: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 181 Wuxi AppTec : Segment Market Shares, 2022
Figure 182 Wuxi AppTec .: Regional Market Shares, 2022
Figure 183 Eurofins Scientific.: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 184 Eurofins Scientific.: Segment Market Shares, 2022
Figure 185 Eurofins Scientific.: Regional Market Shares, 2022
Figure 186 Evotec SE: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 187 Evotec SE: R&D, 2018-2022 (US$ Million, AGR %)
Figure 188 Evotec SE: Regional Market Shares, 2022
Figure 189 Syngene International: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 190 Syngene International: Regional Market Shares, 2022
Figure 191 Bio-Techne: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 192 Bio-Techne: R&D, 2018-2022 (US$ Million, AGR %)
Figure 193 Bio-Techne: Segment Market Shares, 2022
Figure 194 Bio-Techne: Regional Market Shares, 2022
Figure 195 Inotiv: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 196 Inotiv: Segment Market Shares, 2022
Figure 197 Inotiv: Regional Market Shares, 2022
Figure 198 Frontage Labs. : Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 199 Frontage Labs.: R & D, 2018-2022 (US$ Million, AGR %)
Figure 200 Frontage Labs.: Segment Market Shares, 2022
Figure 201 Frontage Labs.: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（consulting）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

医薬品開発業務受託機関（CROs）市場レポート：2023-2033

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（consulting）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?